TRIAL DETAIL

Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor

Drug:	Imatinib
Trial Name:	Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
NCT#:	NCT00764595
Conditions:	Gastrointestinal Stromal Tumor
Status:	Completed
Phase:	2	Start Date 10/01/2008	Age of Trial (yrs) 16.2
Treatment Phase:
Drug Category:	KIT/PDGFRA inhibitor
Strategy:	Block KIT
Trial Type:	Specifically GIST and only GIST
Other Protocol IDs:	CDR000061562, NIIGATAU-TRIGIST0805
Sponsor:	Niigata University medical and dental Hospital
Patient Contact:	See site contact info below
Contact email:
Contact Phone:
Randomized:
IV or Oral:	Oral
Trial Notes:	This trial and the companion trial offering surgery is open at approx. 36 sites in Japan. Contact information is provided here for the principal investigator. Pleas check clinicaltrials.gov for detailed contact information at other sites in Japan. Or use the Netbio links here on each trial web page.

Name	Address	City	State	Zip	Country
Niigata University Medical and Dental School		Niigata		951-8520	Japan